We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Mediclinic International Plc | LSE:MDC | London | Ordinary Share | GB00B8HX8Z88 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 501.00 | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMMDC
RNS Number : 9772Q
Mediclinic International PLC
05 December 2016
Mediclinic International plc
(Incorporated in England and Wales)
Company Number: 08338604
LSE Share Code: MDC
JSE Share Code: MEI
NSX Share Code: MEP
ISIN: GB00B8HX8Z88
5 December 2016
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES -------------------------------------------------------------------------------------------------------------------- 1. Identity of the issuer or the underlying MEDICLINIC INTERNATIONAL PLC issuer of existing shares to which voting rights are attached: -------------------------------------------------------------------- ---------------------------------------------- 2 Reason for the notification (please tick the appropriate box or boxes): -------------------------------------------------------------------------------------------------------------------- An acquisition or disposal of voting rights X ------------------------------------------------------------------------ ------------------------------------------ An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached ------------------------------------------------------------------------ ------------------------------------------ An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments ------------------------------------------------------------------------ ------------------------------------------ An event changing the breakdown of voting rights ------------------------------------------------------------------------ ------------------------------------------ Other (please specify): ------------------------------------------------------------------- --- ------------------------------------------ 3. Full name of person(s) subject PUBLIC INVESTMENT CORPORATION SOC LIMITED to the notification obligation: -------------------------------------------------------------------- ---------------------------------------------- 4. Full name of shareholder(s) N/A (if different from 3.): -------------------------------------------------------------------- ---------------------------------------------- 5. Date of the transaction and date 01 December 2016 on which the threshold is crossed or reached: -------------------------------------------------------------------- ---------------------------------------------- 6. Date on which issuer notified: 02 December 2016 -------------------------------------------------------------------- ---------------------------------------------- 7. Threshold(s) that is/are crossed or reached: 8% -------------------------------------------------------------------- ---------------------------------------------- 8. Notified details: ------------------------------------------------------------------------------------------------------------------------- A: Voting rights attached to shares ------------------------------------------------------------------------------------------------------------------------- Class/type Situation previous Resulting situation after the triggering of to the triggering transaction shares transaction if possible using the ISIN CODE ----------- -------------------------------------------- -------------------------------------------------------------- Number Number Number Number of voting % of voting rights of of of shares rights Shares Voting Rights ----------- -------------------------- ---------------- ------------- -------------------- ------------------------- Direct Direct Indirect Direct Indirect ----------- --------- ----------- ------------ ------------- --------- --------- ------------ ----------- MEI ORDINARY SHARES 59 239 493 58 705 799 7.963% -------------------------- ---------------- ------------- --------- --------- ------------ ----------- B: Qualifying Financial Instruments ------------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ------------------------------------------------------------------------------------------------------------------------- Type of Expiration Exercise/ Number of voting % of voting financial date Conversion Period rights that may rights instrument be acquired if the instrument is exercised/ converted. --------------- ------------------------ ------------------------------- ---------------------- --------------------- NONE N/A N/A N/A N/A --------------- ------------------------ ------------------------------- ---------------------- --------------------- C: Financial Instruments with similar economic effect to Qualifying Financial Instruments ------------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ------------------------------------------------------------------------------------------------------------------------- Type of Exercise Expiration Exercise/ Number of voting % of voting rights financial price date Conversion rights instrument instrument period refers to ------------- ----------- --------------- -------------- ----------------------------------- ----------------------- Nominal Delta ------------- ----------- --------------- -------------- ----------------------------------- ------------ --------- Total (A+B+C) ------------------------------------------------------------------------------------------------------------------------- Number of voting rights Percentage of voting rights ----------------------------------------------------------- ------------------------------------------------------------ 58 705 799 7.963% ----------------------------------------------------------- ------------------------------------------------------------ 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: ------------------------------------------------------------------------------------------- N/A Proxy Voting: ------------------------------------------------------------------------------------------- 10. Name of the proxy holder: N/A ---------------------------------------------------------------------- ------------------- 11. Number of voting rights proxy holder will N/A cease to hold: ---------------------------------------------------------------------- ------------------- 12. Date on which proxy holder will cease to N/A hold voting rights: ---------------------------------------------------------------------- ------------------- 13. Additional information: N/A ---------------------------------------------------------------------- ------------------- 14. Contact name: DEVILLIERS MAKONKO ---------------------------------------------------------------------- ------------------- 15. Contact telephone number: 012 742 3578 ---------------------------------------------------------------------- -------------------
Registered address: 1st Floor, 40 Dukes Place, London, EC3A 7NH, United Kingdom
Website: www.mediclinic.com
Corporate broker: Morgan Stanley & Co International plc
JSE sponsor: Rand Merchant Bank (A division of FirstRand Bank Limited)
NSX sponsor: Simonis Storm Securities (Pty) Ltd
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUVOARNKAURAA
(END) Dow Jones Newswires
December 05, 2016 07:00 ET (12:00 GMT)
1 Year Mediclinic Chart |
1 Month Mediclinic Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions